Parker, Chris <br/><br/>
Re: All-cause mortality in randomized trials of cancer screening.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jun 2002 
 - 861-2; author reply 865-6 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/94.11.861-a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Bias<br/>Cause of Death<br/>Chemotherapy, Adjuvant--adverse effects<br/>Female<br/>Goserelin--adverse effects<br/>Humans<br/>Male<br/>Mass Screening--statistics & numerical data<br/>Prostatic Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Survival Rate